Literature DB >> 2221972

Social integration of the older thalassaemic patient.

C Politis1, A Di Palma, M Fisfis, A Giasanti, S C Richardson, C Vullo, G Masera.   

Abstract

Because social policy favours the fullest possible social integration of chronically ill patients, we have evaluated the facilities that are needed to achieve this for patients with beta thalassaemia major in the light of the therapeutic advances that now permit them to survive into adulthood. We have investigated the social integration of adolescent and young adult thalassaemic patients, 171 from Greece and 112 from Ferrara in Italy. Patients in both areas show a good level of social integration and favourable self image, indicating what may be achieved by providing psychosocial support as part of a comprehensive approach to treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2221972      PMCID: PMC1792101          DOI: 10.1136/adc.65.9.984

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  1 in total

1.  A psychosocial needs assessment of patients with homozygous beta-thalassemia.

Authors:  R Woo; P J Giardina; M W Hilgartner
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

  1 in total
  3 in total

1.  Psychometric properties of the Specific Thalassemia Quality of Life Instrument for adults.

Authors:  Georgios N Lyrakos; Demetra Vini; Helen Aslani; Marouso Drosou-Servou
Journal:  Patient Prefer Adherence       Date:  2012-07-02       Impact factor: 2.711

2.  Psychosocial aspects and psychiatric disorders in young adult with thalassemia major.

Authors:  Giuseppina Messina; Elisa Colombo; Elena Cassinerio; Francesca Ferri; Rita Curti; Carlo Altamura; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2008-06-13       Impact factor: 3.397

3.  Comparative effects of three iron chelation therapies on the quality of life of greek patients with homozygous transfusion-dependent Beta-thalassemia.

Authors:  Vasilis Goulas; Alexandra Kourakli-Symeonidis; Charalambos Camoutsis
Journal:  ISRN Hematol       Date:  2012-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.